Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has submitted copies of newspaper advertisements published on August 6, 2025, relating to its unaudited financial results for the quarter ended June 30, 2025 (Q1FY26). The Board of Directors approved these results at a meeting held on August 5, 2025, with limited review carried out by statutory auditors Deloitte Haskins & Sells. The advertisements were published in English (Business Standard, Hyderabad edition) and Telugu newspapers, as required under SEBI's Listing Regulations. The filing is a routine compliance submission and the detailed financial numbers themselves are not contained in this announcement — they are available on the company's investor page and on the BSE and NSE websites.
This is a standard regulatory disclosure with no new financial data or strategic news. Shareholders should refer to the actual Q1FY26 results on the company's website or stock exchange portals to assess any impact on the stock.